Police & Firemen s Retirement System of New Jersey Boosts Stake in Zoetis Inc. $ZTS

Police & Firemen s Retirement System of New Jersey boosted its holdings in Zoetis Inc. (NYSE:ZTS) by 3.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 67,712 shares of the company’s stock after acquiring an additional 2,156 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Zoetis were worth $10,560,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in ZTS. Savvy Advisors Inc. boosted its stake in shares of Zoetis by 54.0% during the 2nd quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock worth $495,000 after acquiring an additional 1,114 shares in the last quarter. Sound Income Strategies LLC raised its holdings in Zoetis by 54.3% during the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock worth $67,000 after purchasing an additional 152 shares during the last quarter. Canoe Financial LP raised its holdings in Zoetis by 859.0% during the second quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock worth $2,085,000 after purchasing an additional 11,975 shares during the last quarter. Strs Ohio purchased a new stake in Zoetis during the first quarter worth $22,891,000. Finally, Soros Capital Management LLC grew its holdings in Zoetis by 32.0% in the first quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after purchasing an additional 4,230 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Stock Down 0.2%

Shares of NYSE ZTS opened at $121.04 on Friday. The firm has a market cap of $53.34 billion, a P/E ratio of 20.83, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. Zoetis Inc. has a 1 year low of $117.26 and a 1 year high of $181.85. The firm’s 50 day moving average price is $141.57 and its 200 day moving average price is $151.73.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the firm posted $1.58 EPS. Zoetis’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio is 33.67%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on ZTS shares. UBS Group cut their price target on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Stifel Nicolaus set a $140.00 target price on shares of Zoetis in a research report on Tuesday, November 4th. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and reduced their target price for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Finally, Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $180.00.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.